Interview with Matt Stang, CEO of Delic Corp

In this episode of the Psychedelic Spotlight podcast, Psychedelic Investor, James Hallifax interviews Matt Stang, Co-Founder and CEO of Delic Corp. Delic is a psychedelic medicines company focused on bringing psychedelic wellness to the mainstream through their infrastructure of ketamine therapy clinics; the largest in the U.S.

You can find Delic Corp trading on the Canadian Securities Exchange under the symbol $DELC and on the American OTC market under the symbol $DELCF.

*To learn more about Delic, visit their website: DelicCorp.com

Have you heard about our new community?

We’re excited to announce Bonfire -
a personal growth community for people who are interested in psychedelics.

Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.

Sign Up Here